EP1799240A4 - Treatment of bone disorders with skeletal anabolic drugs - Google Patents

Treatment of bone disorders with skeletal anabolic drugs

Info

Publication number: EP1799240A4
Authority: EP; European Patent Office
Prior art keywords: treatment; bone disorders; anabolic drugs; skeletal anabolic; skeletal
Prior art date: 2004-09-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP05797693A

Other languages

German (de)

French (fr)

Other versions

EP1799240A2 (en

Inventor

Andrew F Stewart

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Osteotrophin LLC

Original Assignee

Osteotrophin LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-16

Filing date

2005-09-14

Publication date

2009-07-22

2005-09-14 Application filed by Osteotrophin LLC filed Critical Osteotrophin LLC

2007-06-27 Publication of EP1799240A2 publication Critical patent/EP1799240A2/en

2009-07-22 Publication of EP1799240A4 publication Critical patent/EP1799240A4/en

Status Withdrawn legal-status Critical Current

Links

208000020084 Bone disease Diseases 0.000 title 1
230000001195 anabolic effect Effects 0.000 title 1
239000003814 drug Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Physical Education & Sports Medicine (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

EP05797693A 2004-09-16 2005-09-14 Treatment of bone disorders with skeletal anabolic drugs Withdrawn EP1799240A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US61028304P	2004-09-16	2004-09-16
PCT/US2005/032706 WO2006033912A2 (en)	2004-09-16	2005-09-14	Treatment of bone disorders with skeletal anabolic drugs

Publications (2)

Publication Number	Publication Date
EP1799240A2 EP1799240A2 (en)	2007-06-27
EP1799240A4 true EP1799240A4 (en)	2009-07-22

Family

ID=36090476

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP05797693A Withdrawn EP1799240A4 (en)	2004-09-16	2005-09-14	Treatment of bone disorders with skeletal anabolic drugs

Country Status (6)

Country	Link
EP (1)	EP1799240A4 (en)
JP (1)	JP2008513459A (en)
AU (1)	AU2005287139A1 (en)
CA (1)	CA2580281A1 (en)
MX (1)	MX2007003185A (en)
WO (1)	WO2006033912A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX353986B (en)	2007-08-01	2017-11-06	Massachusetts Gen Hospital	Screening methods using g-protein coupled receptors and related compositions.
EP2509996A1 (en)	2009-12-07	2012-10-17	Michigan Technological University	Black bear parathyroid hormone and methods of using black bear parathyroid hormone
MX358161B (en)	2010-05-13	2018-08-06	The General Hospital Corp Star	Parathyroid hormone analogs and uses thereof.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1531855A4 (en) *	2002-01-10	2009-07-22	Osteotrophin Llc	Treatment of bone disorders with skeletal anabolic drugs
US7906480B2 (en) *	2002-05-23	2011-03-15	Michael Holick	Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy

2005
- 2005-09-14 CA CA002580281A patent/CA2580281A1/en not_active Abandoned
- 2005-09-14 JP JP2007532415A patent/JP2008513459A/en active Pending
- 2005-09-14 AU AU2005287139A patent/AU2005287139A1/en not_active Abandoned
- 2005-09-14 EP EP05797693A patent/EP1799240A4/en not_active Withdrawn
- 2005-09-14 MX MX2007003185A patent/MX2007003185A/en not_active Application Discontinuation
- 2005-09-14 WO PCT/US2005/032706 patent/WO2006033912A2/en active Application Filing

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HORWITZ MARA J ET AL: "Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis.", THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM FEB 2003, vol. 88, no. 2, February 2003 (2003-02-01), pages 569 - 575, XP002530462, ISSN: 0021-972X *

Also Published As

Publication number	Publication date
WO2006033912A2 (en)	2006-03-30
WO2006033912B1 (en)	2006-09-08
EP1799240A2 (en)	2007-06-27
JP2008513459A (en)	2008-05-01
WO2006033912A3 (en)	2006-06-29
AU2005287139A1 (en)	2006-03-30
MX2007003185A (en)	2007-10-16
CA2580281A1 (en)	2006-03-30

Legal Events

Date	Code	Title	Description
2007-05-25	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2007-06-27	17P	Request for examination filed	Effective date: 20070412
2007-06-27	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
2007-12-26	DAX	Request for extension of the european patent (deleted)
2009-07-22	A4	Supplementary search report drawn up and despatched	Effective date: 20090618
2010-02-12	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2010-03-17	18D	Application deemed to be withdrawn	Effective date: 20090918

Publication	Publication Date	Title
IL185052A0 (en)	2007-12-03	Treatment of bone disorders
HK1207821A1 (en)	2016-02-12	Improved modalities for the treatment of degenerative diseases of the retina
IL178815A0 (en)	2007-05-15	The treatment of respiratory disease
TWI372056B (en)	2012-09-11	Novel medicament combinations for the treatment of respiratory diseases
EP2166837A4 (en)	2011-12-21	Drug combination for the treatment of skin disorders
IL184425A0 (en)	2007-10-31	Cxcr4 antagonists for the treatment of medical disorders
IL188204A0 (en)	2008-03-20	Combination therapy for the treatment of immunoinflammatory disorders
EP1926521A4 (en)	2009-10-21	Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
HK1171736A1 (en)	2013-04-05	Substituted acids for the treatment of respiratory diseases
IL178730A0 (en)	2007-03-08	New pharmaceutical compositions for the treatment of sexual disorders ii
GB0522311D0 (en)	2005-12-07	Pharmaceutical compositions for the treatment of pain
IL181049A0 (en)	2007-07-04	Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
IL190652A0 (en)	2008-12-29	Novel pharmaceutical combinations for the treatment of respiratory disorders
EP1962869A4 (en)	2011-01-12	Treatment of respiratory diseases
GB0404656D0 (en)	2004-04-07	Treatment of spinal conditions
GB0410399D0 (en)	2004-06-16	The treatment of respiratory disease
HK1111599A1 (en)	2008-08-15	Pharmaceutical compositions for the treatment of cellulite
EP1799240A4 (en)	2009-07-22	Treatment of bone disorders with skeletal anabolic drugs
EP1924286A4 (en)	2010-01-13	Phrophylactic and/or therapeutic method for treatment of autoimmune disease
GB0400802D0 (en)	2004-02-18	Compounds for the treatment of disease
EP1846013A4 (en)	2009-09-09	Treatment of skin diseases
ZA200607463B (en)	2008-10-29	New pharmaceutical compositions for the treatment of sexual disorders II
GB0419828D0 (en)	2004-10-13	The treatment of inflammatroy disorders and pain
GB0417474D0 (en)	2004-09-08	Treatment of respiratory disorders
GB0423245D0 (en)	2004-11-24	Treatment of breathing disorders